PellePharm – Patient Worthy

Source: pixabay.com

LEO Pharma Funds PellePharm’s Phase 3 Trial of Promising Gorlin Syndrome Drug

Post author:Scott Carlson
Post published:November 26, 2018
Post category:Rare Disease

According to an article published by CheckOrphan, LEO Pharma and PellePharm have announced a new multi-million dollar partnership together with the aim of advancing research for rare skin diseases that…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More